NeuroPace, Inc. (NPCE:NASDAQ) closed at $12.50 on November 6, 2026, down 1.50% on the day. The stock trades 36.2% below its 52-week high of $19.60 and 4.2% above its 52-week low of $12.00. Over the past year, it lost 7.1%. NeuroPace, Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, NPCE closed higher on 131 days (52%). Its best day was November 24, 2025 (+13.31%) and its worst was May 11, 2026 (-14.60%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Find more stocks like NPCE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.